{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:59:31Z","timestamp":1767707971618,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K01HL142847","R01HL15705","R01HL160749","K24HL160527"],"award-info":[{"award-number":["K01HL142847","R01HL15705","R01HL160749","K24HL160527"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK133465"],"award-info":[{"award-number":["R01DK133465"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","award":["Research Starter Award"],"award-info":[{"award-number":["Research Starter Award"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s40256-024-00671-3","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T14:55:21Z","timestamp":1723560921000},"page":"693-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 Diagnosis, Oral Anticoagulation, and Stroke Risk in Patients with Atrial Fibrillation"],"prefix":"10.1007","volume":"24","author":[{"given":"Lanting","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangbin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingchuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid F.","family":"Gellad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utibe R.","family":"Essien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared W.","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0118-4986","authenticated-orcid":false,"given":"Inmaculada","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"671_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.brainresbull.2021.12.011","volume":"180","author":"Y Cui","year":"2022","unstructured":"Cui Y, Zhao B, Li T, Yang Z, Li S, Le W. Risk of ischemic stroke in patients with COVID-19 infection: a systematic review and meta-analysis. Brain Res Bull. 2022;180:31\u20137. https:\/\/doi.org\/10.1016\/j.brainresbull.2021.12.011.","journal-title":"Brain Res Bull"},{"key":"671_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175501","volume":"941","author":"GP Massoud","year":"2023","unstructured":"Massoud GP, Hazimeh DH, Amin G, Mekary W, Khabsa J, Araji T, Fares S, Mericskay M, Booz GW, Zouein FA. Risk of thromboembolic events in non-hospitalized COVID-19 patients: a systematic review. Eur J Pharmacol. 2023;941: 175501. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175501.","journal-title":"Eur J Pharmacol"},{"key":"671_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0140-6736(21)02392-8","volume":"399","author":"E Ramacciotti","year":"2022","unstructured":"Ramacciotti E, Barile Agati L, Calderaro D, Aguiar VCR, Spyropoulos AC, de Oliveira CCC, Lins dos Santos J, Volpiani GG, Sobreira ML, Joviliano EE, et al. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. Lancet. 2022;399:50\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(21)02392-8.","journal-title":"Lancet"},{"key":"671_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2021.04.005","volume":"238","author":"RD Lopes","year":"2021","unstructured":"Lopes RD, DeBarros ESPGM, Furtado RHM, Macedo AVS, Ramacciotti E, Damini LP, Bronhara B, Cavalcanti AB, Rosa RG, Azevedo LCP, et al. Randomized clinical trial to evaluate a routine full anticoagulation strategy in patients with coronavirus infection (SARS-CoV2) admitted to hospital: rationale and design of the ACTION (anticoagulation coronavirus)-coalition IV trial. Am Heart J. 2021;238:1\u201311. https:\/\/doi.org\/10.1016\/j.ahj.2021.04.005.","journal-title":"Am Heart J."},{"key":"671_CR5","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1136\/heartjnl-2022-320845","volume":"108","author":"P Raatikainen","year":"2022","unstructured":"Raatikainen P, Lassila R. COVID-19: another reason for anticoagulation in patients with atrial fibrillation. Heart. 2022;108:902\u20134. https:\/\/doi.org\/10.1136\/heartjnl-2022-320845.","journal-title":"Heart"},{"key":"671_CR6","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/jcm10112490","volume":"10","author":"GF Romiti","year":"2021","unstructured":"Romiti GF, Corica B, Lip GYH, Proietti M. Prevalence and impact of atrial fibrillation in hospitalized patients with COVID-19: a systematic review and meta-analysis. J Clin Med. 2021;10:2490.","journal-title":"J Clin Med"},{"key":"671_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.thromres.2021.05.006","volume":"203","author":"W Ageno","year":"2021","unstructured":"Ageno W, De Candia E, Iacoviello L, Di Castelnuovo A. Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study. Thromb Res. 2021;203:138\u201341. https:\/\/doi.org\/10.1016\/j.thromres.2021.05.006.","journal-title":"Thromb Res"},{"key":"671_CR8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1055\/a-1503-3875","volume":"122","author":"S Fumagalli","year":"2021","unstructured":"Fumagalli S, Trevisan C, Del Signore S, Pelagalli G, Volpato S, Gareri P, Mossello E, Malara A, Monzani F, Coin A, et al. COVID-19 and atrial fibrillation in older patients: does oral anticoagulant therapy provide a survival benefit?\u2014an insight from the GeroCovid registry. Thromb Haemost. 2021;122:105\u201312. https:\/\/doi.org\/10.1055\/a-1503-3875.","journal-title":"Thromb Haemost"},{"key":"671_CR9","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/heartjnl-2021-320325","volume":"108","author":"A Handy","year":"2022","unstructured":"Handy A, Banerjee A, Wood AM, Dale C, Sudlow CLM, Tomlinson C, Bean D, Thygesen JH, Mizani MA, Katsoulis M, et al. Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort. Heart. 2022;108:923\u201331. https:\/\/doi.org\/10.1136\/heartjnl-2021-320325.","journal-title":"Heart"},{"key":"671_CR10","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0735-1097(22)02789-9","volume":"79","author":"D Louis","year":"2022","unstructured":"Louis D, Kennedy K, Saad M, Salber G, Imran Hafiz M, Wark T, Soares C, Ghosalkar D, Cherala R, Poppas A, et al. Pre-admission oral anticoagulation is associated with fewer thrombotic complications in patients admitted with covid-19. J Am Coll Cardiol. 2022;79:1798\u20131798. https:\/\/doi.org\/10.1016\/S0735-1097(22)02789-9.","journal-title":"J Am Coll Cardiol"},{"key":"671_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2024.100396","volume":"42","author":"I Hernandez","year":"2024","unstructured":"Hernandez I, Yang L, Tang S, Cameron T, Guo J, Gabriel N, Essien UR, Magnani JW, Gellad WF. COVID-19 pandemic and trends in clinical outcomes and medication use for patients with established atrial fibrillation: a nationwide analysis of claims data. Am Heart J Plus Cardiol Res Practice. 2024;42: 100396. https:\/\/doi.org\/10.1016\/j.ahjo.2024.100396.","journal-title":"Am Heart J Plus Cardiol Res Practice"},{"key":"671_CR12","unstructured":"Service CfMaM. Chronic conditions data warehouse data dictionaries; 2020. https:\/\/www2.ccwdata.org\/web\/guest\/data-dictionaries. Accessed December 2016."},{"key":"671_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jacc.2019.01.011","volume":"74","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol. 2019;74:104\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2019.01.011.","journal-title":"J Am Coll Cardiol"},{"key":"671_CR14","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s40256-019-00388-8","volume":"20","author":"TV Newman","year":"2020","unstructured":"Newman TV, Chen N, He M, Saba S, Hernandez I. Effectiveness and safety of restarting oral anticoagulation in patients with atrial fibrillation after an intracranial hemorrhage: analysis of medicare part D claims data from 2010\u20132016. Am J Cardiovasc Drugs. 2020;20:471\u20139. https:\/\/doi.org\/10.1007\/s40256-019-00388-8.","journal-title":"Am J Cardiovasc Drugs"},{"key":"671_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0281068","volume":"18","author":"I Hernandez","year":"2023","unstructured":"Hernandez I, He M, Guo J, Tadrous M, Gabriel N, Swabe G, Gellad WF, Essien UR, Saba S, Benjamin EJ, et al. COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: a nationwide analysis of claims data. PLoS ONE. 2023;18: e0281068. https:\/\/doi.org\/10.1371\/journal.pone.0281068.","journal-title":"PLoS ONE"},{"key":"671_CR16","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1161\/01.str.0000032240.28636.bd","volume":"33","author":"DL Tirschwell","year":"2002","unstructured":"Tirschwell DL, Longstreth WT Jr. Validating administrative data in stroke research. Stroke. 2002;33:2465\u201370. https:\/\/doi.org\/10.1161\/01.str.0000032240.28636.bd.","journal-title":"Stroke"},{"key":"#cr-split#-671_CR17.1","unstructured":"Prevention CfDCa. New ICD-10-CM code for the 2019 novel coronavirus (COVID-19)"},{"key":"#cr-split#-671_CR17.2","unstructured":"2020. https:\/\/www.cdc.gov\/nchs\/data\/icd\/Announcement-New-ICD-code-for-coronavirus-3-18-2020.pdf. Accessed April 2022."},{"key":"671_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/s12872-023-03614-z","volume":"23","author":"L Yang","year":"2023","unstructured":"Yang L, Tang S, He M, Guo J, Gabriel N, Swabe G, Gellad WF, Essien UR, Saba S, Benjamin EJ, et al. COVID-19 pandemic and initiation of treatment for atrial fibrillation: a nationwide analysis of claims data. BMC Cardiovasc Disord. 2023;23:604. https:\/\/doi.org\/10.1186\/s12872-023-03614-z.","journal-title":"BMC Cardiovasc Disord"},{"key":"671_CR19","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.18553\/jmcp.2021.27.12.1672","volume":"27","author":"L Yang","year":"2021","unstructured":"Yang L, Guo J, Liang Q, Newman TV, Gellad WF, Hernandez I. Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation. J Manage Care Spec Pharm. 2021;27:1672\u20139. https:\/\/doi.org\/10.18553\/jmcp.2021.27.12.1672.","journal-title":"J Manage Care Spec Pharm"},{"key":"671_CR20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.011427","volume":"8","author":"I Hernandez","year":"2019","unstructured":"Hernandez I, He M, Chen N, Brooks MM, Saba S, Gellad WF. Trajectories of oral anticoagulation adherence among medicare beneficiaries newly diagnosed with atrial fibrillation. J Am Heart Assoc. 2019;8: e011427. https:\/\/doi.org\/10.1161\/JAHA.118.011427.","journal-title":"J Am Heart Assoc"},{"key":"671_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s40256-019-00371-3","volume":"20","author":"I Hernandez","year":"2020","unstructured":"Hernandez I, He M, Brooks MM, Saba S, Gellad WF. Adherence to anticoagulation and risk of stroke among medicare beneficiaries newly diagnosed with atrial fibrillation. Am J Cardiovasc Drugs. 2020;20:199\u2013207. https:\/\/doi.org\/10.1007\/s40256-019-00371-3.","journal-title":"Am J Cardiovasc Drugs"},{"key":"671_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.18553\/jmcp.2022.28.2.266","volume":"28","author":"TV Newman","year":"2022","unstructured":"Newman TV, Gabriel N, Liang Q, Drake C, El Khoudary SR, Good CB, Gellad WF, Hernandez I. Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs medicare advantage prescription drug plans. J Manage Care Spec Pharm. 2022;28:266\u201374. https:\/\/doi.org\/10.18553\/jmcp.2022.28.2.266.","journal-title":"J Manage Care Spec Pharm"},{"key":"671_CR23","doi-asserted-by":"publisher","first-page":"e1921357","DOI":"10.1001\/jamanetworkopen.2019.21357","volume":"3","author":"N Chen","year":"2020","unstructured":"Chen N, Brooks MM, Hernandez I. Latent classes of adherence to oral anticoagulation therapy among patients with a new diagnosis of atrial fibrillation. JAMA Netw Open. 2020;3:e1921357\u2013e1921357. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.21357.","journal-title":"JAMA Netw Open"},{"key":"671_CR24","first-page":"A60","volume":"4","author":"JT DeFrank","year":"2007","unstructured":"DeFrank JT, Bowling JM, Rimer BK, Gierisch JM, Skinner CS. Triangulating differential nonresponse by race in a telephone survey. Prev Chron Dis. 2007;4:A60.","journal-title":"Prev Chron Dis"},{"key":"671_CR25","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/STROKEAHA.115.012609","volume":"47","author":"A Joundi Raed","year":"2016","unstructured":"Joundi Raed A, Cipriano Lauren E, Sposato Luciano A, Saposnik G. Ischemic stroke risk in patients with atrial fibrillation and CHA2DS2-VASc score of 1. Stroke. 2016;47:1364\u20137. https:\/\/doi.org\/10.1161\/STROKEAHA.115.012609.","journal-title":"Stroke"},{"key":"671_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/clc.22435","volume":"38","author":"W Zhu","year":"2015","unstructured":"Zhu W, He W, Guo L, Wang X, Hong K. The HAS-BLED score for predicting major bleeding risk in anticoagulated patients with atrial fibrillation: a systematic review and meta-analysis. Clin Cardiol. 2015;38:555\u201361. https:\/\/doi.org\/10.1002\/clc.22435.","journal-title":"Clin Cardiol"},{"key":"671_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.amjcard.2020.03.034","volume":"126","author":"L Yang","year":"2020","unstructured":"Yang L, Brooks M, Glynn N, Zhang Y, Saba S, Hernandez I. Real-world direct comparison of the effectiveness and safety of apixaban, dabigatran, rivaroxaban, and warfarin in medicare beneficiaries with atrial fibrillation. Am J Cardiol. 2020;126:29\u201336. https:\/\/doi.org\/10.1016\/j.amjcard.2020.03.034.","journal-title":"Am J Cardiol"},{"key":"671_CR28","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1016\/j.amjcard.2017.07.092","volume":"120","author":"I Hernandez","year":"2017","unstructured":"Hernandez I, Zhang Y, Saba S. Comparison of the effectiveness and safety of apixaban, dabigatran, rivaroxaban, and warfarin in newly diagnosed atrial fibrillation. Am J Cardiol. 2017;120:1813\u20139. https:\/\/doi.org\/10.1016\/j.amjcard.2017.07.092.","journal-title":"Am J Cardiol"},{"key":"671_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11940-023-00747-6","volume":"25","author":"\u0395 Stefanou","year":"2023","unstructured":"Stefanou \u0395, Karvelas N, Bennett S, Kole C. Cerebrovascular manifestations of SARS-CoV-2: A comprehensive review. Curr Treat Opt Neurol. 2023;25:71\u201392. https:\/\/doi.org\/10.1007\/s11940-023-00747-6.","journal-title":"Curr Treat Opt Neurol"},{"key":"671_CR30","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s11239-020-02228-y","volume":"50","author":"YK Tan","year":"2020","unstructured":"Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, Tu TM, Sharma VK, Yeo LLL, Chan BPL, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. J Thromb Thrombolysis. 2020;50:587\u201395. https:\/\/doi.org\/10.1007\/s11239-020-02228-y.","journal-title":"J Thromb Thrombolysis"},{"key":"671_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fstro.2023.1172854","author":"Y Kim","year":"2023","unstructured":"Kim Y, Parekh MA, Li X, Huang Y, Zhang G-Q, Manwani B. Age and sex-specific stroke epidemiology in COVID-19. Front Stroke. 2023. https:\/\/doi.org\/10.3389\/fstro.2023.1172854.","journal-title":"Front Stroke"},{"key":"671_CR32","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/ajh.25982","volume":"95","author":"TC Hanff","year":"2020","unstructured":"Hanff TC, Mohareb AM, Giri J, Cohen JB, Chirinos JA. Thrombosis in COVID-19. Am J Hematol. 2020;95:1578\u201389. https:\/\/doi.org\/10.1002\/ajh.25982.","journal-title":"Am J Hematol"},{"key":"671_CR33","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","volume":"60","author":"Y Guo","year":"2012","unstructured":"Guo Y, Lip GYH, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60:2263\u201370. https:\/\/doi.org\/10.1016\/j.jacc.2012.04.063.","journal-title":"J Am Coll Cardiol"},{"key":"671_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2020.100631","volume":"30","author":"M Gawa\u0142ko","year":"2020","unstructured":"Gawa\u0142ko M, Kap\u0142on-Cie\u015blicka A, Hohl M, Dobrev D, Linz D. COVID-19 associated atrial fibrillation: incidence, putative mechanisms and potential clinical implications. Int J Cardiol Heart Vasc. 2020;30: 100631. https:\/\/doi.org\/10.1016\/j.ijcha.2020.100631.","journal-title":"Int J Cardiol Heart Vasc"},{"key":"671_CR35","doi-asserted-by":"publisher","first-page":"e456","DOI":"10.3399\/bjgp.2021.0689","volume":"72","author":"AY Wong","year":"2022","unstructured":"Wong AY, Tomlinson L, Brown JP, Elson W, Walker AJ, Schultze A, Morton CE, Evans D, Inglesby P, MacKenna B, et al. Association between oral anticoagulants and COVID-19-related outcomes: a population-based cohort study. Br J Gen Pract. 2022;72:e456\u201363. https:\/\/doi.org\/10.3399\/bjgp.2021.0689.","journal-title":"Br J Gen Pract"},{"key":"671_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.amjcard.2022.07.006","volume":"181","author":"DW Louis","year":"2022","unstructured":"Louis DW, Kennedy KF, Saad M, Salber G, Imran H, Wark T, Soares C, Ghosalkar D, Cherala R, Poppas A, et al. Preadmission oral anticoagulation for atrial fibrillation\/flutter and death or thrombotic events during COVID-19 admission. Am J Cardiol. 2022;181:38\u201344. https:\/\/doi.org\/10.1016\/j.amjcard.2022.07.006.","journal-title":"Am J Cardiol"},{"key":"671_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0301421","volume":"19","author":"K Rekk","year":"2024","unstructured":"Rekk K, Arnet I, Dietrich F, Polymeris AA, Lyrer PA, Engelter ST, Schaedelin S, Allemann SS. Relationship between electronically monitored adherence to direct oral anticoagulants and ischemic or hemorrhagic events after an initial ischemic stroke\u2014a case control study. PLoS ONE. 2024;19: e0301421. https:\/\/doi.org\/10.1371\/journal.pone.0301421.","journal-title":"PLoS ONE"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00671-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-024-00671-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00671-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T16:10:16Z","timestamp":1724515816000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-024-00671-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["671"],"URL":"https:\/\/doi.org\/10.1007\/s40256-024-00671-3","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"type":"print","value":"1175-3277"},{"type":"electronic","value":"1179-187X"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"31 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was funded by the National Heart, Lung and Blood Institute (grants K01HL142847 and R01HL15705). Dr. Magnani is funded by R01HL160749 and K24HL160527. Dr. Guo is funded by NIDDK R01DK133465 and PhRMA Foundation Research Starter Award. The funders had no role in design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript, and decision to submit the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Inmaculada Hernandez has received consulting fees from Pfizer and Bristol Myers Squibb, outside of the submitted work. Lanting Yang, Shangbin Tang, Jingchuan Guo, Nico Gabriel, Walid F Gellad, Utibe R. Essien, and Jared W. Magnani no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"L.Y. carried out conceptualization, data curation, analysis, methodology and writing. S.T. carried out data curation, analysis, methodology, reviewing, and editing. J.G. carried out the investigation, methodology, validation, and reviewing and editing. N.G. carried out and planned the methodology, data curation, validation, and reviewing and editing. W.F.G. carried out the investigation, supervision, validation, and reviewing and editing. U.R.E. carried out the investigation, supervision, validation, and reviewing and editing. J.W.M. carried out the investigation, supervision, validation, and reviewing and editing. I.H. carried out the conceptualization, methodology, investigation, supervision, writing, and reviewing and editing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"The datasets generated and\/or analyzed during the current study are available from the corresponding author upon reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"The Institutional Review Board at the University of California, San Diego approved this study as exempt as deidentified data were used in analyses.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}